These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2527624)

  • 1. Thromboxane A2 receptor antagonists. II. Synthesis and pharmacological activity of 6,6-dimethylbicyclo[3.1.1]heptane derivatives with the benzenesulfonylamino group.
    Seno K; Hagishita S
    Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):948-54. PubMed ID: 2527624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of thromboxane receptor antagonists with bicyclo[3.1.0]hexane ring systems.
    Kamata S; Haga N; Tsuri T; Uchida K; Kakushi H; Arita H; Hanasaki K
    J Med Chem; 1990 Jan; 33(1):229-39. PubMed ID: 2136917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboxane A2 receptor antagonists. III. Synthesis and pharmacological activity of 6,6-dimethylbicyclo[3.1.1]heptane derivatives with a substituted sulfonylamino group at C-2.
    Seno K; Hagishita S
    Chem Pharm Bull (Tokyo); 1989 Jun; 37(6):1524-33. PubMed ID: 2528414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboxane A2 receptor antagonists. I. Synthesis and pharmacological activity of 7-oxabicyclo-[2.2.1]heptane derivatives with the benzenesulfonylamino group.
    Hagishita S; Seno K
    Chem Pharm Bull (Tokyo); 1989 Feb; 37(2):327-35. PubMed ID: 2525965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and in vitro activity of various derivatives of a novel thromboxane receptor antagonist, (+/-)-(5Z)-7-[3-endo-[(phenylsulfonyl)amino]bicyclo[2.2.1] hept-2-exo-yl]heptenoic acid.
    Narisada M; Ohtani M; Watanabe F; Uchida K; Arita H; Doteuchi M; Hanasaki K; Kakushi H; Otani K; Hara S
    J Med Chem; 1988 Sep; 31(9):1847-54. PubMed ID: 2970551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and in vitro activity of stereoisomers of a novel thromboxane receptor antagonist, (+-)-(5Z)-7-[3-endo-[(phenylsulfonyl)amino]bicyclo [2.2.1]hept-2-exo-yl]heptenoic acid.
    Ohtani M; Narisada M
    J Med Chem; 1990 Mar; 33(3):1027-31. PubMed ID: 2137879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aza-substituted omega-side-chain modifications of 7-oxabicyclo[2.2.1]heptane thromboxane A2 receptor antagonists: structure-activity relationships.
    Nakane M; Reid JA; Haslanger MF; Garber DP; Harris DN; Ogletree ML; Greenberg R
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():291-3. PubMed ID: 3004140
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of platelet thromboxane A2/prostaglandin H2 receptor by a novel thromboxane receptor antagonist, [3H]S-145.
    Hanasaki K; Nagasaki T; Arita H
    Biochem Pharmacol; 1989 Jun; 38(12):2007-17. PubMed ID: 2525906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and pharmacological evaluation of 5,6-exo-epoxy-7-oxabicyclo[2.2.1]heptane derivatives.
    Das J; Vu T; Harris DN; Ogletree ML
    J Med Chem; 1988 May; 31(5):930-5. PubMed ID: 2966247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different effects of two thromboxane A2/prostaglandin H2 receptor ligands, U46619 and S-145, on rabbit platelets.
    Nakano T; Hanasaki K; Arita H
    FEBS Lett; 1988 Jul; 234(2):309-12. PubMed ID: 2968921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and in vitro pharmacology of 7-oxabicyclo[2.2.1]heptane analogues of thromboxane A2/PGH2.
    Sprague PW; Heikes JE; Gougoutas JZ; Malley MF; Harris DN; Greenberg R
    J Med Chem; 1985 Nov; 28(11):1580-90. PubMed ID: 4067988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a new compound, S-145, as a specific TXA2 receptor antagonist in platelets.
    Hanasaki K; Arita H
    Thromb Res; 1988 May; 50(3):365-76. PubMed ID: 2839912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
    Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
    J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonistic actions of S-145 on vascular and platelet thromboxane A2 receptors.
    Mihara S; Hara S; Ueda M; Ide M; Fujimoto M
    Eur J Pharmacol; 1989 Nov; 171(2-3):179-87. PubMed ID: 2533558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of thromboxane A2/prostaglandin H2 receptors of various tissues using a new radioiodinated thromboxane A2/prostaglandin H2 mimetic, I-BOP.
    Morinelli TA; Naka M; Masuda A; Oatis JE; Okwu AK; Mais DE; Saussy DL; Halushka PV
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():331-7. PubMed ID: 1825565
    [No Abstract]   [Full Text] [Related]  

  • 16. Stereocontrolled synthesis of 7-oxabicyclo (2.2.1) heptane prostaglandin analogs as thromboxane A2 antagonists.
    Sprague PW; Heikes JE; Harris DN; Greenberg R
    Adv Prostaglandin Thromboxane Res; 1980; 6():493-6. PubMed ID: 7189952
    [No Abstract]   [Full Text] [Related]  

  • 17. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S; Nakahata N; Ohizumi Y
    Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of prostanoids with bicyclo[2.2.1]heptane, bicyclo[3.1.1]heptane, and bicyclo[2.2.2]octane ring systems. Activities of 15-hydroxy epimers on human platelets.
    Wilson NH; Peesapati V; Jones RL; Hamilton K
    J Med Chem; 1982 May; 25(5):495-500. PubMed ID: 7086834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a novel thromboxane A2 receptor antagonist, S-145, on collagen-induced ECG changes and thrombocytopenia in rodents.
    Hori Y; Hatakeyama H; Yamada K; Kurosawa A
    Jpn J Pharmacol; 1989 Jun; 50(2):195-205. PubMed ID: 2528013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    Yin K; Halushka PV; Yan YT; Wong PY
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.